Takuya Hinoda1, Yasutaka Fushimi1, Tomohisa Okada1,2, Tsutomu Okada1, Akira Yamamoto1, and Togashi Kaori1
1Radiology, Graduate school of Medicine, Kyoto University, Kyoto, Japan, 2Human Brain Research Center, Graduate school of Mediine, Kyoto University, Kyoto, Japan
Synopsis
Gadolinium-based contrast agents (GBCAs) have
been widely used for contrast material-enhanced magnetic resonance (MR)
imaging. However, gadolinium accumulation in the dentate nucleus (DN) has
gained attention due to recent studies. In this study, we retrospectively
evaluated the susceptibility values of DN, using quantitative susceptibility
mapping. The susceptibility values of the patients with GBCA administration
were significantly higher than those of normal controls.Purpose
Quantitative
susceptibility mapping (QSM) has become a robust technique to measure voxel-wise
tissue magnetic susceptibility from phase images. QSM can provide
in vivo quantitative susceptibility value
12. Gadolinium-based contrast agents (GBCAs) have
been widely used for contrast material-enhanced magnetic resonance (MR)
imaging. However, gadolinium accumulation in the
dentate nucleus (DN) has gained attention due to recent studies
3-6. These recent
studies have focused T1 shortening effect of gadolinium in the DN on T1-weighted
images, and susceptibility
changes have not been evaluated due
to a paramagnetic
effect of Gadolinium
Materials and Methods
Subjects
We retrospectively enrolled 49 patients who
had underwent contrast enhanced-MR imaging and 49 healthy volunteers to establish normal
database for QSM.
MR
imaging
All MR
scans were performed at3T MR scanner (Magnetom Skyra, or Trio, Siemens, Erlangen,
Germany). Three-dimensional (3D) axial gradient-echo
sequence (repetition time (TR) / echo time (TE) /ΔTE, 55 ms / 3.6-45.0 ms / 5.91 ms ; resolution;
0.9×0.9×2.0 mm) and 3D sagittal T1-weighted
image (VIBE: TR/TE, 6.0/2.29; flip angle, 15°; resolution, 0.9×0.9×0.9, or
MPRAGE: TR/TE/TI, 1900/2.58/900; flip angle, 9°; resolution,
0.9×0.9×0.9) were used. 3D
sagittal T1-weighted images were reconstructed to axial plane parallel to the
axial images manually.
Post-processing
QSM
calculation was conducted from the magnitude and phase images of the gradient
echo images by STI Suite
version 2.10 (http://people.duke.edu/~cl160/). At
first, we conducted phase unwrapping and background phase removal using the
sophisticated harmonic artifact reduction for phase data with a variable radius
of the spherical kernel at the brain boundary (V-SHARP method 78. Then, QSM was reconstructed from
the local tissue phase images by solving an inverse problem using the algorithm
for sparse linear equations and sparse least squares (iLSQR method)7 .
Data
analysis
A region
of interest (ROI) study was performed. The mean of the susceptibility values of
the DN were measured and T1 ratio was defined as follows: mean values of the DN
divided by those of the cerebellar white matter.
Statistics
We performed the unpaired t test with the Welch
correlation to assess the difference of susceptibility values and T1 ratio
between GBCA group (patients) and non-GBCA group (healthy volunteers). We also assessed the regression analysis between
susceptibility values or T1 ratio and the number of the GBCA administration,
and the regression analysis between susceptibility values and the T1 ratio. All the statistical analysis were conducted using MedCalc version 13.3 (MedCalc Software bvba,
Ostend, Belgium). P
values of less than .05 indicated a
statistically significant difference.
Results
The subjects’ characteristics are shown in
Table 1. There were no patients with renal dysfunction. The age distribution
between the GBCA group and non-GBCA group was not significantly different (P=0.317). Typical images of QSM and T1-weighted images are shown in Figure 1.
Susceptibility
value and T1 ratio between GBCA and non-GBCA group
The susceptibility values at DN in GBCA
group was significantly higher than those of non-GBCA group (GBCA group,
0.187ppm±0.031, non-GBCA group, 0.081ppm±0.026, P<0.0001) (Fig. 2). T1 ratio
at DN in GBCA group was also significantly higher than that in non-GBCA group
(GBCA group, 1.053±0.071, non-GBCA group, 0.989±0.023, P<0.0001) (Fig. 3)
Discussion
QSM could
detect the susceptibility change due to paramagnetic substance. Gadolinium is
the very strong paramagnetic substance. In current study, we focused on the
gadolinium deposition in the DN. Gadolinium usually never exist in the human body, but
Kanda et al demonstrated that Gadolinium deposition in the DN due to serial
GBCA administration. This phenomenon were reported to be observed as high
intensity of T1 weighted images in the DN. Susceptibility change of GBCA group
against non-GBCA group reflect the gadolinium deposition due to serial GBCA
administration. the result of our study also reconfirmed the accumulation of
Gadolinium in the DN, specifically the higher susceptibility values in the DN
on the GBCA group.
Conclusion
QSM can also detect the susceptibility
changes in dentate nucleus due to gadolinium deposition from serial enhanced MR
scans.
Acknowledgements
We thank Dr. Chunlei Liu, Duke University, for providing us STI Suite. We are grateful to Mr. Katutoshi Murata and Mr. Yuta Urushibata, Siemens Japan K.K., for their useful comments on this study. This work was supported by JSPS KAKENHI Grant Number 25461815.References
1. Hinoda T, Fushimi Y, Okada T, et al. Quantitative
Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and
Reproducibility. Investigative radiology. 2015;50(8):522-30.
2. Deh K, Nguyen TD, Eskreis-Winkler S, et al.
Reproducibility of quantitative susceptibility mapping in the brain at two
field strengths from two vendors. Journal of magnetic resonance imaging : JMRI.
2015.
3. Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based
Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal
Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma
Mass Spectroscopy. Radiology. 2015;276(1):228-32.
4. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D.
High signal intensity in the dentate nucleus and globus pallidus on unenhanced
T1-weighted MR images: relationship with increasing cumulative dose of a
gadolinium-based contrast material. Radiology. 2014;270(3):834-41.
5. Kanda T, Osawa M, Oba H, et al. High Signal Intensity in
Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear
versus Macrocyclic Gadolinium Chelate Administration. Radiology.
2015;275(3):803-9.
6. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial
Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology.
2015;275(3):772-82.
7. Li W, Avram AV, Wu B, Xiao X, Liu C. Integrated
Laplacian-based phase unwrapping and background phase removal for quantitative
susceptibility mapping. NMR in biomedicine. 2014;27(2):219-27.
8. Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility
mapping using compressed sensing. Magnetic resonance in medicine : official
journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic
Resonance in Medicine. 2012;67(1):137-47.